The 2nd Intersessional Meeting of the 61st session of the Commission on Narcotic Drugs took place in Vienna on the 25th of June 2018. The meeting started with Chair Alicia Buenrostro Massieu of Mexico presenting the agenda for adoption, then proceeded to the first agenda point: Follow-up to the regular 61st session of CND, resolution …
Russia
Committee of the Whole (Friday Afternoon) – Final meeting. Various resolutions.
L4.Rev 1 – Algeria, Andorra, Belarus, China, Indonesia, Pakistan, Russian Federation, Vietnam, Thailand, Sri Lanka, Switzerland… Outlines extra-budgetary resources required. Invites commission to adopt the resolution. Any statements? No. Co-sponsors – Iraq, Pakistan, Peru, Bosnia Herzegovia, Honduras, El Salvador, Libya, Lichtenstein, Nigeria, Paraguay, Philippines L5. Rev 1 – no financial implications. Cosponsor – Peru, Norway, …
Committee of the Whole – Friday afternoon (L2 – Protecting children from illicit drug threat)
Chair: We are going to take on L2, then go back to L11 Russia: We are ready to go and wish to be flexible. Chair: Comments on the title? Russia: We’re running out of time; we are happy to reframe the title: ‘Protecting children from the illicit drug challenge’ Chair: Title approved. Russia: These are …
Plenary Session: Item 8. Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem
Chair: The CND in its follow up process to the Special Session aims to foster cooperation with other ECOSOC commissions: status of women, statistical, science and development. This provides an opportunity for further collaboration, interaction and information exchange. Head of Treaty Affairs, UNODC: As we know, the UNGASS outcome document reaffirmed the importance of collaboration …
Committee of the Whole (Thursday Afternoon) – Resolution L11. Removing stigma as a barrier to the availability and delivery of health, case and social services for people who use drugs
L11 Chair: We may not move in chronological order. I want to mention I intend to continue our session in the evening because we have very little time left. I invite us to focus on L11. China: Regarding the night session we have some concerns because we have many experts who wish to speak in …
Special Event: Taking Action to Increase Access to Controlled Drugs for Medical Purposes While Preventing Diversion and Misuse
Dr Lisa Studdert, Australia’s Head of Delegation Australia is deeply concern on the global disparity on global access to essential medicines. We need to work together. Adequate provision must be made to ensure access. It’s very important that the conventions do no restrict access. We need to reduce the risks of diversion for illicit use. …